Filing Details
- Accession Number:
- 0001209191-11-002534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-07 19:29:54
- Reporting Period:
- 2011-01-06
- Filing Date:
- 2011-01-07
- Accepted Time:
- 2011-01-07 19:29:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397266 | K Matthew Fust | C/O Onyx Pharmaceuticals, Inc. 2100 Powell St., 12Th Floor Emeryville CA 94608 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-01-06 | 1,812 | $37.28 | 18,101 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- Includes 1,832 shares purchased through the issuer's ESPP.
Billionaire Hedge Funds
